Page last updated: 2024-08-21

nicotinamide mononucleotide and Atherosclerosis

nicotinamide mononucleotide has been researched along with Atherosclerosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balasubramanian, P; Csipo, T; Csiszar, A; Farkas, E; Gautam, T; Giles, CB; Kiss, T; Lipecz, A; Nyúl-Tóth, Á; Szabo, C; Tarantini, S; Ungvari, Z; Wren, JD; Yabluchanskiy, A1

Other Studies

1 other study(ies) available for nicotinamide mononucleotide and Atherosclerosis

ArticleYear
Nicotinamide mononucleotide (NMN) supplementation promotes anti-aging miRNA expression profile in the aorta of aged mice, predicting epigenetic rejuvenation and anti-atherogenic effects.
    GeroScience, 2019, Volume: 41, Issue:4

    Topics: Aging; Animals; Aorta; Atherosclerosis; Dietary Supplements; Endothelium, Vascular; Epigenesis, Genetic; Gene Expression Profiling; Mice, Inbred C57BL; MicroRNAs; Nicotinamide Mononucleotide; Rejuvenation

2019